The objective of this project is to establish that residues 696-894 of the hamster sulfonylurea receptor (SUR1) encode a nucleotide binding domain (NBF1). Furthermore, we hypothesize binding and hydrolysis of Mg- ATP by NBF1 has structural consequences which will help understand the mechanism of SUR1 triggered insulin release. Lastly, we propose NBF1 may also contain sulfonylurea binding sites which affect its nucleotide binding and hydrolysis ability.
Aim I is to design, express and purify to homogeneity residues 696-894 of SUR1.
Aim II is to characterize the nucleotide and sulfonylurea binding ability of-NBF1 using intrinsic tryptophan fluorescence, isothermal titration calorimetry and site specific NMR.
Aim III will further-characterize NBF1 by establishing its ATPase activity. Finally, Aim IV is to define the structural and dynamic properties of the nucleotide binding reaction using solution-state NMR. This study will provide potential mechanisms for sulfonylurea action in SUR1 as well as structurally explain genetic variations in SUR1 in relation to diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM019834-03
Application #
6351143
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Cassatt, James
Project Start
1999-07-12
Project End
Budget Start
2001-01-11
Budget End
2002-01-10
Support Year
3
Fiscal Year
2001
Total Cost
$40,196
Indirect Cost
Name
Washington University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130